Swiss National Bank Aurinia Pharmaceuticals Inc. Transaction History

Swiss National Bank

$167 Billion
Q3 2025

A detailed history of Swiss National Bank transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Swiss National Bank holds 222,900 shares of AUPH stock, worth $3.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,900

Previous 235,800 5.47%

Holding current value

$3.42 Million

Previous $1.9 Million 29.97%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$7.47 - $13.14 $96,363 - $169,506	-12,900 Reduced 5.47%	222,900 $2.46 Million
Q1 2025 May 12, 2025	SELL	$7.55 - $8.77 $24,160 - $28,064	-3,200 Reduced 1.34%	235,800 $1.9 Million
Q4 2024 Feb 10, 2025	SELL	$6.75 - $10.44 $176,850 - $273,528	-26,200 Reduced 9.88%	239,000 $2.15 Million
Q3 2024 Nov 07, 2024	SELL	$5.32 - $7.33 $17,556 - $24,189	-3,300 Reduced 1.23%	265,200 $1.94 Million
Q4 2023 Feb 06, 2024	SELL	$7.13 - $9.49 $215,326 - $286,598	-30,200 Reduced 10.11%	268,500 $2.41 Million

Q3 2023 Nov 08, 2023	BUY	$7.77 - $12.27 $150,738 - $238,038	19,400 Added 6.95%	298,700 $2.32 Million
Q2 2023 Aug 09, 2023	BUY	$8.96 - $11.69 $166,656 - $217,434	18,600 Added 7.13%	279,300 $2.7 Million
Q1 2023 May 10, 2023	SELL	$5.94 - $11.27 $181,170 - $343,735	-30,500 Reduced 10.47%	260,700 $2.86 Million
Q4 2022 Feb 08, 2023	BUY	$4.11 - $8.14 $22,605 - $44,770	5,500 Added 1.93%	291,200 $1.26 Million
Q3 2022 Nov 09, 2022	BUY	$6.66 - $12.39 $167,166 - $310,989	25,100 Added 9.63%	285,700 $2.15 Million
Q1 2022 May 09, 2022	BUY	$10.05 - $22.48 $205,020 - $458,592	20,400 Added 8.49%	260,600 $3.23 Million
Q4 2021 Feb 08, 2022	BUY	$17.78 - $33.08 $243,586 - $453,196	13,700 Added 6.05%	240,200 $5.49 Million
Q3 2021 Nov 08, 2021	BUY	$10.93 - $23.55 $10,930 - $23,550	1,000 Added 0.44%	226,500 $5.01 Million
Q2 2021 Aug 06, 2021	SELL	$10.0 - $14.52 $204,000 - $296,208	-20,400 Reduced 8.3%	225,500 $2.93 Million
Q1 2021 May 07, 2021	BUY	$12.3 - $18.73 $23,370 - $35,587	1,900 Added 0.78%	245,900 $3.2 Million
Q3 2020 Nov 09, 2020	BUY	$13.19 - $16.66 $836,246 - $1.06 Million	63,400 Added 35.11%	244,000 $3.58 Million
Q2 2020 Aug 05, 2020	BUY	$14.12 - $18.33 $327,584 - $425,255	23,200 Added 14.74%	180,600 $2.91 Million
Q1 2020 May 08, 2020	BUY	$11.34 - $21.46 $55,566 - $105,154	4,900 Added 3.21%	157,400 $2.24 Million
Q4 2019 Feb 06, 2020	BUY	$3.88 - $21.42 $118,340 - $653,310	30,500 Added 25.0%	152,500 $3.08 Million
Q3 2019 Nov 12, 2019	BUY	$5.34 - $6.59 $54,468 - $67,218	10,200 Added 9.12%	122,000 $651,000
Q2 2019 Aug 02, 2019	BUY	$6.05 - $6.75 $82,885 - $92,475	13,700 Added 13.97%	111,800 $738,000
Q4 2018 Feb 13, 2019	BUY	$5.08 - $6.83 $28,956 - $38,931	5,700 Added 6.17%	98,100 $667,000
Q4 2017 Feb 07, 2018	BUY	$4.53 - $7.09 $418,572 - $655,116	92,400	92,400 $421,000

Others Institutions Holding AUPH

# of Institutions

269

Shares Held

69.3M

Call Options Held

984K

Put Options Held

574K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $2.18B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Aurinia Pharmaceuticals Inc. Transaction History